Pervasis Therapeutics Lands $12,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6f3e092d-0c79-410e-a304-3e4e505c4478&Preview=1
Date
9/30/2005
Company Name
Pervasis Therapeutics
Mailing Address
One Kendall Square, Building 600 Cambridge, MA 02139
Company Description
Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
Website
http://www.pervasistx.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,000
Transaction Round
Series B
Proceeds Purposes
The financing will be used to continue clinical development of the company’s first product, a combination device for patients with vascular disease.
M&A Terms
Venture Investor
Polaris Venture Partners
Venture Investor
Highland Capital Partners
Venture Investor
Flagship Ventures